AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 188 filers reported holding AKERO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $112 | +107.4% | 10,600 | -5.4% | 0.01% | +37.5% |
| Q2 2023 | $54 | -19.4% | 11,200 | -41.4% | 0.01% | +14.3% |
| Q1 2023 | $67 | -78.4% | 19,100 | -61.7% | 0.01% | -73.1% |
| Q4 2022 | $310 | -99.7% | 49,900 | +10.6% | 0.03% | +333.3% |
| Q3 2022 | $98,000 | +263.0% | 45,100 | +1704.0% | 0.01% | +500.0% |
| Q1 2021 | $27,000 | +12.5% | 2,500 | +56.2% | 0.00% | -50.0% |
| Q3 2020 | $24,000 | +9.1% | 1,600 | +60.0% | 0.00% | +100.0% |
| Q2 2020 | $22,000 | +266.7% | 1,000 | +233.3% | 0.00% | – |
| Q1 2020 | $6,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Skorpios Trust | 3,271,829 | $125,180,178 | 50.58% |
| COMMODORE CAPITAL LP | 790,000 | $30,225,400 | 4.60% |
| Redmile Group, LLC | 2,044,389 | $78,218,323 | 3.39% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 202,561 | $7,749,984 | 3.20% |
| Ghost Tree Capital, LLC | 275,000 | $10,522,000 | 3.11% |
| Avidity Partners Management LP | 2,447,000 | $93,622,220 | 3.11% |
| Atlas Venture Life Science Advisors, LLC | 594,251 | $22,736,043 | 3.08% |
| Logos Global Management LP | 400,000 | $15,304,000 | 2.19% |
| Yiheng Capital Management, L.P. | 1,125,791 | $43,072,764 | 1.70% |
| Boxer Capital, LLC | 831,495 | $31,813 | 1.56% |